Evidence map›Paper›PMID 42818955›Full record

ArticleResearch square2026

Determinants and Strategies for Implementation of the HOPE Self-Sampling Cervical Screening Intervention for Women Living with HIV in Ghana: A Context Assessment and Implementation Mapping Study.

Nadia Adjoa Sam-Agudu, Karen Awura-Adjoa Ronke Coker, Emily Frueh, Obed Cudjoe, Sebastian Ken-Amoah, Nancy Innocentia Ebu Enyan, Gloria F Nuer-Allornuvor, Emmanuel Abrefah, Alex Boadi Dankyi, Patrick Kafui Akakpo and 2 more

Registry-linked trialAbstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06800664 (The Impact of an Evidence-Based, Behavioral Cervical Cancer Screening Intervention Among Women Living With HIV in Ghana), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06800664 narecruitingnot on this map

The Impact of an Evidence-Based, Behavioral Cervical Cancer Screening Intervention Among Women Living With HIV in Ghana (HOPE-inG): A Type 2 Hybrid Effectiveness Implementation Trial

TypeinterventionalSponsorBaylor UniversityRan2025 to 2029Enrolled1,500ConditionsCervical Cancer Screening, HIV, Self-sampling, Implementation ScienceArmsHealth providers and management at IG sites will receive ISS (i.e., management support, capacity-building, and social network support) and training on the HOPE implementation plan, Control Group
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nadia Adjoa Sam-AguduUniversity of Minnesota Medical School.
Karen Awura-Adjoa Ronke CokerUniversity of Minnesota Medical School.
Emily FruehBaylor University.
Obed CudjoeUniversity of Cape Coast.
Sebastian Ken-AmoahUniversity of Cape Coast.
Nancy Innocentia Ebu EnyanUniversity of Cape Coast.
Gloria F Nuer-AllornuvorCape Coast Teaching Hospital.
Emmanuel AbrefahBaylor University.
Alex Boadi DankyiUniversity of Cape Coast.
Patrick Kafui AkakpoUniversity of Cape Coast.
Dorcas Obiri-YeboahUniversity of Cape Coast.
Matthew AsareBaylor University.

Funding

The Impact of an Evidence-Based, Behavioral Cervical Cancer Screening Intervention among Women Living with HIV in Ghana (HOPE-inG): A Type 2 Hybrid Effectiveness Implementation TrialU01CA294757 · NCI · BAYLOR UNIVERSITY · PI Matthew Asare, Dorcas Obiri-Yeboah · 2024 to 2026
$1.4M
NCI NIH HHS U01 CA294757
6 · The paper itself

Abstract

Background: In Ghana, fewer than 5% of women eligible for cervical screening access this intervention. This screening gap has significant implications for early detection and treatment, especially for women living with HIV (WLWH), who are at higher risk of developing and dying from cervical cancer.The HOPE-in-Ghana (HOPE-inG) study aimed to identify determinants of implementation for the HOPE self-sampling cervical screening intervention in Ghana's Central Region and to select implementation strategies to optimize its implementation in this context. Methods: We applied the nominal group technique in a rapid context assessment with four purposively sampled stakeholder groups. Participants independently generated ideas on determinants of HOPE implementation, shared their ideas, provided clarifications, and voted to prioritize them. The Consolidated Framework for Implementation Research (CFIR) was used to categorize nominal group data as follows: determinants relevant to the Innovation (HOPE intervention); Inner setting (health facility sites of implementation); Outer setting (policy); Individuals (intervention recipients, deliverers, and decision-makers) and the Implementation Process. Prioritized determinants judged addressable within the study's scope were then mapped to implementation strategies listed in the Expert Recommendations for Implementing Change (ERIC) taxonomy and specified using published reporting guidance. Results: We conducted four nominal groups among 65 participants, including WLWH, healthcare workers, clinic managers and government officials that identified determinants largely concentrated in the CFIR Inner Setting, Outer Setting and Implementation Process domains. Analysis yielded 29 prioritized and addressable determinants (14 facilitators and 15 barriers) which were mapped to 24 strategies, with focus on training and educating stakeholders, using evaluative and iterative strategies, stakeholder engagement, and providing interactive assistance, leading to the development of targeted job aids. Conclusions: Bridging the gap between evidence and practice requires consideration of both context and stakeholder interests. Our context assessment highlighted key changes in policy, health facility staff and environment, and implementation processes as critical to the successful integration of HPV self-sampling into Ghana's HIV program and health system. Accordingly, we identified relevant implementation strategies to inform actionable job aids. We will evaluate whether these implementation support strategies improve adoption, cost, fidelity, penetration, and sustainability of the HOPE cervical screening intervention in our study setting. Trial registration: ClinicalTrials.gov NCT06800664. Registered on 29 January 2025.

Indexed as

Early detection of cancerGhanaHIVimplementation scienceimplementation support strategiesuterine cervical neoplasms

Identifiers

PMID42818955
PMCPMC13622832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.